Dr Yvette Drew is a Consultant Medical Oncologist at BC Cancer Centre Vancouver and Associate Professor at the University of British Columbia, she moved to Canada in May 2021. She specializes in the systemic management of gynaecological cancers and early phase clinical trial delivery. She is part of the OVCARE team in Vancouver. Previously Dr Drew worked as a Senior Lecturer and Consultant in Medical Oncology at the Northern Centre for Cancer Care (NCCC) and the Clinical and Translational Research Institute, Newcastle University where she was gynae medical oncology research lead, deputy lead for the Newcastle Experimental Cancer Medicines Centre and undertook basic laboratory gynae focused research within the gynae-onc translational team.
Dr Drew undertook specialist medical oncology training at the Beatson West of Scotland Cancer Centre, Glasgow and the NCCC. During this time she was awarded a CRUK-funded PhD fellowship investigating the role of PARP inhibitors in Homologous Recombination deficient ovarian cancer. During her PhD she won a Merit award for her research from the American Society of Clinical Oncology (ASCO) and was awarded the Medical Sciences Doctoral Prize (Newcastle university, 2013). She has played a key role in both the pre-clinical and clinical development of the PARP inhibitor rucaparib in ovarian cancer. In the UK she has also led on trials as national CI from first-in-human phase 1 to later phase 3 clinical trials. Research interests include the targeting DNA repair pathways as treatment for gynaecological cancers and PARP inhibitor resistance.